Replies to post #103543 on Cytodyn Inc (CYDY)

[All-Bidness]

Absolutely. I think if we are able to show a reduction in viral load, we have a winner, as those patients won't move on to the next phase. Team that up with the fact we are 64% safer than the placebo...I don't see how we can't get a p4 with EUA.

[misiu143]

This is a study where all primary , secondary and “Others “ points will be evaluate very closely , and ALL very important .

How was blood oxygenation and progress , how long if at all on oxygen , if ventilator was use , when ,
all the blood tests done with Rantes , different cytokines , CD4 , CD8 , T- cells , at 3,7,14 days ,
how long hospitalization , viral load , if any mortality , must be evaluated why...

All those will be more important to FDA and everyone then length off cough ..as we know cough after respiratory infection may last for couple of months ..

From Dr NP and Dr Lalezari description , all results should be extremely impressive .

Talking about SAE Dr Lalezari said ..:

" I did about 300 studies , I never saw such a good results “


All imo as always ..